Dr Olakanmi Joseph Deleawe, MD | |
100 Mercy Way, Joplin, MO 64804-4524 | |
(417) 556-2727 | |
Not Available |
Full Name | Dr Olakanmi Joseph Deleawe |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 12 Years |
Location | 100 Mercy Way, Joplin, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033515168 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 2017022828 (Missouri) | Secondary |
208M00000X | Hospitalist | 2017022828 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Joplin | Joplin, MO | Hospital |
Freeman Health System - Freeman West | Joplin, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Clinic Joplin Llc | 0547300196 | 247 |
Landmark Hospital Of Joplin Llc | 5698870822 | 8 |
News Archive
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
A hospital in Britain which has been at the forefront of heart transplant surgery ever since it carried out the UK's first successful operation in 1979, is in trouble.
› Verified 4 days ago
Entity Name | Ssm Audrain Health Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841334836 PECOS PAC ID: 3678481827 Enrollment ID: O20040129000368 |
News Archive
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
A hospital in Britain which has been at the forefront of heart transplant surgery ever since it carried out the UK's first successful operation in 1979, is in trouble.
› Verified 4 days ago
Entity Name | Landmark Hospital Of Joplin Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972633410 PECOS PAC ID: 5698870822 Enrollment ID: O20080312000432 |
News Archive
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
A hospital in Britain which has been at the forefront of heart transplant surgery ever since it carried out the UK's first successful operation in 1979, is in trouble.
› Verified 4 days ago
Entity Name | Mercy Clinic Joplin Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215264817 PECOS PAC ID: 0547300196 Enrollment ID: O20091218000092 |
News Archive
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
A hospital in Britain which has been at the forefront of heart transplant surgery ever since it carried out the UK's first successful operation in 1979, is in trouble.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Olakanmi Joseph Deleawe, MD 100 Mercy Way, Joplin, MO 64804-4524 Ph: (417) 556-2727 | Dr Olakanmi Joseph Deleawe, MD 100 Mercy Way, Joplin, MO 64804-4524 Ph: (417) 556-2727 |
News Archive
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.
Researchers at the University of Granada and the university hospital Virgen de las Nieves in Granada have developed a new radiotherapy technique that is much less toxic than that traditionally used and only targets cancerous tissue.
A hospital in Britain which has been at the forefront of heart transplant surgery ever since it carried out the UK's first successful operation in 1979, is in trouble.
› Verified 4 days ago
David Michael Dawson, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1102 W 32nd St, Joplin, MO 64804 Phone: 417-347-4570 Fax: 417-347-6755 | |
Dr. Roberto Antonio Moran-bojorquez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Mercy Way, Joplin, MO 64804 Phone: 417-556-2300 Fax: 417-556-3625 | |
Gretchen Marie Christian, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1102 W 32nd St, Joplin, MO 64804 Phone: 417-347-4570 | |
Doris Carrizales Purvis, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 100 Mercy Way, Joplin, MO 64804 Phone: 417-781-2727 Fax: 417-208-3625 | |
Justin D Wilberding, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1102 W 32nd St, Joplin, MO 64804 Phone: 417-347-4570 | |
Muhammad Saad Farooq, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 100 Mercy Way, Joplin, MO 64804 Phone: 417-556-2727 | |
Adam Lawrence Magiera, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1102 W 32nd St, Joplin, MO 64804 Phone: 417-347-1111 |